NEW YORK (GenomeWeb News) – Advanced Biological Laboratories said today it signed a non-exclusive agreement with Roche Diagnostics for the promotion of certain ABL products.

In particular, the deal is aimed at promoting ABL's next-generation sequencing platform called DeepChek with Roche's NGS systems, the 454 GS Junior and 454 GS FLX+, for molecular virology. The deal covers Europe, the Middle East, Africa, and Latin America.

DeepChek is a solution for managing and analyzing NGS data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.